Core beliefs in healthy youth and youth at ultra high-risk for psychosis: Dimensionality and links to depression, anxiety, and attenuated psychotic symptoms.


Journal

Development and psychopathology
ISSN: 1469-2198
Titre abrégé: Dev Psychopathol
Pays: United States
ID NLM: 8910645

Informations de publication

Date de publication:
02 2019
Historique:
pubmed: 7 3 2018
medline: 18 5 2019
entrez: 7 3 2018
Statut: ppublish

Résumé

Cognitive theory posits that core beliefs play an active role in developing and maintaining symptoms of depression, anxiety, and psychosis. This study sought to comprehensively examine core beliefs, their dimensionality, and their relationships to depression, anxiety, and attenuated psychotic symptoms in two groups of community youth: a group at ultrahigh risk for psychosis (UHR; n = 73, M age = 18.7) and a matched healthy comparison group (HC; n = 73, M age = 18.1). UHR youth reported significantly more negative beliefs about self and others, and significantly less positive beliefs about self and others. HC youth rarely endorsed negative self-beliefs. Exploratory factor analyses found that HC negative self-beliefs did not cohere as a single factor. We hypothesized specific links between core beliefs and symptoms based on cognitive models of each disorder, and tested these links through regression analyses. The results in the HC group were consistent with the proposed models of depression and anxiety. The results in the UHR group were consistent with proposed models of depression and negative psychotic symptoms, somewhat consistent with a proposed model of positive psychotic symptoms, and not at all consistent with a proposed model of anxiety. These findings add to a growing developmental literature on core beliefs and psychopathology, with important clinical implications.

Identifiants

pubmed: 29506584
pii: S0954579417001912
doi: 10.1017/S0954579417001912
pmc: PMC6127011
mid: NIHMS923975
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

379-392

Subventions

Organisme : NIMH NIH HHS
ID : R01 MH094650
Pays : United States
Organisme : NIMH NIH HHS
ID : R21 MH103231
Pays : United States
Organisme : NIMH NIH HHS
ID : R33 MH103231
Pays : United States
Organisme : CIHR
ID : DFS-152268
Pays : Canada

Références

Psychiatr Q. 1999 Winter;70(4):273-87
pubmed: 10587984
Neuropsychology. 2011 May;25(3):295-305
pubmed: 21443341
Br J Clin Psychol. 1998 Nov;37(4):415-30
pubmed: 9856295
Schizophr Res. 2013 Aug;148(1-3):175-80
pubmed: 23773297
Behav Cogn Psychother. 2016 Mar;44(2):203-13
pubmed: 25896713
Early Interv Psychiatry. 2008 Aug;2(3):147-53
pubmed: 21352147
Am J Psychiatry. 1993 Nov;150(11):1643-8
pubmed: 8105706
Psychometrika. 1965 Jun;30:179-85
pubmed: 14306381
Am Psychol. 1993 Feb;48(2):155-68
pubmed: 8442570
Arch Gen Psychiatry. 2012 Jun;69(6):562-71
pubmed: 22664547
Schizophr Res. 2006 Sep;86(1-3):181-8
pubmed: 16857346
Psychol Med. 2016 Apr;46(5):981-94
pubmed: 26620582
Psychiatry Res. 2014 May 30;216(3):303-13
pubmed: 24630916
Schizophr Res. 2005 Sep 1;77(1):11-24
pubmed: 16005381
Psychol Med. 2006 Jun;36(6):749-59
pubmed: 16563204
Br J Psychiatry. 2012 Jan;200(1):22-9
pubmed: 22075649
Psychiatry Res. 2016 May 30;239:333-41
pubmed: 27058160
J Clin Psychol. 1958 Oct;14(4):365-6
pubmed: 13575572
J Nerv Ment Dis. 2000 Jan;188(1):19-25
pubmed: 10665456
Psychol Med. 2001 Feb;31(2):189-95
pubmed: 11232907
Mol Psychiatry. 2011 Jan;16(1):67-75
pubmed: 19949389
Behav Cogn Psychother. 2014 Nov;42(6):718-30
pubmed: 23920050
Mol Psychiatry. 2011 Sep;16(9):885-6
pubmed: 21358709
Schizophr Bull. 2014 Jan;40(1):120-31
pubmed: 23180756
Can J Psychiatry. 2005 Apr;50(5):247-57
pubmed: 15968839
Arch Gen Psychiatry. 2009 Jan;66(1):13-20
pubmed: 19124684
Behav Cogn Psychother. 2009 Mar;37(2):227-31
pubmed: 19364422
Psychiatry Res. 2012 Apr 30;196(2-3):220-4
pubmed: 22445704
Psychopathology. 1998;31(3):160-8
pubmed: 9636945
Psychopathology. 2009;42(6):375-9
pubmed: 19752591
JAMA Psychiatry. 2013 Jan;70(1):107-20
pubmed: 23165428
Arch Gen Psychiatry. 2010 Jul;67(7):683-91
pubmed: 20603449
Schizophr Res. 2008 Feb;99(1-3):119-24
pubmed: 18023329
Child Dev. 2001 Nov-Dec;72(6):1723-46
pubmed: 11768142
J Abnorm Psychol. 2013 Nov;122(4):1121-31
pubmed: 24364615
Schizophr Bull. 2016 Sep;42(5):1197-206
pubmed: 26994398
Trends Cogn Sci. 2008 Nov;12(11):441-6
pubmed: 18805040
Neurosci Biobehav Rev. 2009 Jun;33(6):807-17
pubmed: 19428493
J Abnorm Psychol. 1998 May;107(2):216-27
pubmed: 9604551
Psychiatry Res. 2014 Feb 28;215(2):323-8
pubmed: 24370335
Neuropsychol Rev. 2009 Sep;19(3):280-93
pubmed: 19597747
Scand J Psychol. 1999 Mar;40(1):21-31
pubmed: 10216461
Perspect Psychol Sci. 2013 May;8(3):272-95
pubmed: 26172971
Arch Gen Psychiatry. 2010 Jan;67(1):47-57
pubmed: 20048222
Psychoneuroendocrinology. 2015 Jul;57:26-36
pubmed: 25880698
J Abnorm Psychol. 2008 Nov;117(4):812-25
pubmed: 19025228

Auteurs

Dan P McAdams (DP)

Northwestern University.

Vijay A Mittal (VA)

Northwestern University.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH